Overview

The Effects of Dupilumab on Allergic Contact Dermatitis

Status:
Recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate the effects of dupilumab on allergic contact dermatitis.
Phase:
Phase 4
Details
Lead Sponsor:
Brigham and Women's Hospital
Collaborator:
Regeneron Pharmaceuticals
Treatments:
Antibodies, Monoclonal